CAS: 1093070-16-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GRL0617 REF: TM-T11464CAS: 1093070-16-6 | 99.31% | 36.00 €~1,095.00 € | Wed 08 Jan 25 |
 | GRL0617 REF: IN-DA01KKBVCAS: 1093070-16-6 | 98% | To inquire | Wed 08 Jan 25 |
 | GRL 0617 REF: 3D-BG178727CAS: 1093070-16-6 | Min. 98 Area-% | 206.00 €~1,033.00 € | Tue 21 Jan 25 |
GRL0617
CAS:1093070-16-6
GRL0617 is a selective and competitive SARS-CoVPLpro and deubiquitinase noncovalent inhibitor(IC50 : 0.6 μM, Ki …
Formula:
C20H20N2O
Purity:
99.31%
Color and Shape:
Solid
Molecular weight:
304.39
Ref: TM-T11464
| 1mg | 36.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 109.00 € | ||
| 25mg | 185.00 € | ||
| 50mg | 322.00 € | ||
| 100mg | 518.00 € | ||
| 500mg | 1,095.00 € | ||
| 1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Wednesday 8 Jan 2025
Ref: IN-DA01KKBV
| 1mg | 194.00 € | ||
| 5mg | 562.00 € | ||
| 10mg | 608.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 8 Jan 2025
GRL 0617
CAS:1093070-16-6
A novel non-covalent inhibitor of the PLpro protease from SARS-CoV-2 and SARS-CoV viruses. GRL 0617 …
Formula:
C20H20N2O
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
304.39 g/mol
Ref: 3D-BG178727
| 5mg | 206.00 € | ||
| 10mg | 271.00 € | ||
| 25mg | 406.00 € | ||
| 50mg | 633.00 € | ||
| 100mg | 1,033.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
